PDT Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

PDT Partners’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-71,297	Closed	-$1.12M	–	772
2024 Q1	$1.12M	Sell	71,297 -68	-0.1%	-$1.05K	0.11%	309
2023 Q4	$1.15M	Buy	71,365 +35,863	+101%	+$457K	0.13%	264
2023 Q3	$452K	Buy	+35,502	New	+$490K	0.06%	426
2023 Q1	–	Sell	-22,510	Closed	-$369K	–	740
2022 Q4	$369K	Sell	22,510 -90,870	-80%	-$1.48M	0.06%	445
2022 Q3	$2.1M	Sell	113,380 -65,531	-37%	-$1.03M	0.32%	59
2022 Q2	$2.35M	Sell	178,911 -43,432	-20%	-$479K	0.21%	136
2022 Q1	$2.06M	Buy	+222,343	New	+$1.89M	0.18%	165

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

PDT Partners's DCPH Position: Q2 2024 in Review

PDT Partners sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 71,297 shares — an estimated $1.12M sold.

PDT Partners first reported a position in DCPH in Q1 2022 and held it in 7 quarters. The position peaked at $2.35M in Q2 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

PDT Partners reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
PDT Partners sold 71,297 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.12M.
PDT Partners first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
PDT Partners's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.35M in Q2 2022.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on PDT Partners's 13F filing for Q2 2024, filed 15 Aug 2024.